Browse By Cell Line Result Page of OvirusTdb
The total number of records retrieved from this search are 12. Click on ID to see further detail.
IDOV_4607 | Virus nameAdenovirus | Virus strainAd5/3-CB016 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 VP per cell | In-vitro result100% cell viablity after 3 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4608 | Virus nameAdenovirus | Virus strainAd5/3-CB016 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration10 VP per cell | In-vitro result100% cell viablity after 3 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4609 | Virus nameAdenovirus | Virus strainAd5/3-CB016 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration100 VP per cell | In-vitro result70% cell viablity after 3 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4610 | Virus nameAdenovirus | Virus strainAd5/3-delata 24 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 and delta 24 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 VP per cell | In-vitro result100% cell viablity after 3 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4611 | Virus nameAdenovirus | Virus strainAd5/3-delata 24 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 and delta 24 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration10 VP per cell | In-vitro result50% cell viablity after 3 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4612 | Virus nameAdenovirus | Virus strainAd5/3-delata 24 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 and delta 24 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration100 VP per cell | In-vitro result10% cell viablity after 3 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4613 | Virus nameAdenovirus | Virus strainAd5/3-CB016 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 VP per cell | In-vitro result70% cell viablity after 7 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4614 | Virus nameAdenovirus | Virus strainAd5/3-CB016 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration10 VP per cell | In-vitro result58 cell viablity after 7 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4615 | Virus nameAdenovirus | Virus strainAd5/3-CB016 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration100 VP per cell | In-vitro result10% cell viablity after 7 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4616 | Virus nameAdenovirus | Virus strainAd5/3-delata 24 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 and delta 24 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 VP per cell | In-vitro result100% cell killing after 7 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4617 | Virus nameAdenovirus | Virus strainAd5/3-delata 24 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 and delta 24 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration10 VP per cell | In-vitro result100% cell killing after 7 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |
IDOV_4618 | Virus nameAdenovirus | Virus strainAd5/3-delata 24 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationMutation in delta E3 and delta 24 gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineVU university medical centre, Netherland | Origin of cell lineHuman neck and squamous cell carcinoma cell line | Cell line93VU147T | Concentration of cell line3000 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration100 VP per cell | In-vitro result100% cell killing after 7 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27086483 |